𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment options for primary splenic low-grade non-Hodgkin's lymphomas

✍ Scribed by V. Gh. MUSTEATA; I. T. CORCIMARU; I. A. IACOVLEVA; L. Z. MUSTEATA; I. S. SUHARSCHII; L. T. ANTOCI

Book ID
108701639
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
76 KB
Volume
26
Category
Article
ISSN
1751-5521

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Radiation therapy for localized low-grad
Radiation therapy for localized low-grade non-Hodgkin's lymphomas
✍ Richard W. Tsang; Mary K. Gospodarowicz πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 382 KB

The most common low grade B-cell non-Hodgkin's lymphomas are follicular lymphomas, and extranodal marginal zone lymphomas, also known as mucosa-associated lymphoid tissue (MALT) lymphomas. Localized presentations of follicular lymphoma occur in 20-30% of cases, while for MALT lymphomas, stage I-II d

Treatment patterns in low-grade non-Hodg
Treatment patterns in low-grade non-Hodgkin's lymphomas: A single institution study
✍ Liesveld, Jane L. ;Raubertas, Richard F. ;Bennett, John M. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 599 KB

Ninety-two cases of low-grade non-Hodgkin's lymphoma were examined retrospectively to assess to what extent treatment deferral is practiced at a single university hospital with a local referral base. Clinical characteristics of this patient group were also analyzed; 70% of these cases were of nodula

Treatment of low-grade non-Hodgkin's lym
Treatment of low-grade non-Hodgkin's lymphomas: Assessment of doxorubicin in a controlled trial
✍ Dr. E. Lepage; C. Sebban; C. Gisselbrecht; B. Coiffier; J. L. Harousseau; P. A. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 501 KB

From 1981 to 1984 a randomized clinical trial was conducted to evaluate the role of doxorubicin in low grade malignancy non-Hodgkin's lymphoma (NHL). One hundred and thirteen patients were treated by an induction regimen including cyclophosphamide 400 mg/m2 day I and 8, vincristine 1.4 mg/m2 day 1 a